Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
about
Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survivalPeroxisome proliferator-activated receptor agonists prevent 25-OH-cholesterol induced c-jun activation and cell deathTaxol induces caspase-10-dependent apoptosisSelective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell linesMPF governs the assembly and contraction of actomyosin rings by activating RhoA and MAPK during chemical-induced cytokinesis of goat oocytesIcaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cellsRegulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger proteinIdentification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells.Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in micePretubulysin: a new option for the treatment of metastatic cancer.An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells2-Phenyl-5-(pyrrolidin-1-yl)-1-(3,4,5-trimethoxybenzyl)-1H-benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c-Jun N-terminal kinase.Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways.Microtubule depolymerization in Caenorhabditis elegans touch receptor neurons reduces gene expression through a p38 MAPK pathwayPharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1)Rhein lysinate inhibits cell growth by modulating various mitogen-activated protein kinases in cervical cancer cells.Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcriptionInvolvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells.Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105.Paclitaxel: a review of adverse toxicities and novel delivery strategies.Loss of the spectraplakin short stop activates the DLK injury response pathway in Drosophila.Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development.Targeting SRC and tubulin in mucinous ovarian carcinoma.Investigation of Targetin, a Microtubule Binding Agent which Regresses the Growth of Pediatric High and Low Grade Gliomas.Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine.Effects of colchicine on renal fibrosis and apoptosis in obstructed kidneys.Microtubule destabilising agents: far more than just antimitotic anticancer drugs.Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway.Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells.Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview.Effect of somatostatin analogue octreotide in medulloblastoma in xenograft and cell culture study.Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition.Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively.Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells.Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasome inhibitors.
P2860
Q22254636-2811F1E6-22F8-4D88-BCDC-A7656635CB6CQ24795891-ED46FA5A-948F-49A5-B58D-D4209E1F0D1FQ28285037-8FF9AE80-66F2-4F6D-86A0-A943343F66D7Q28344057-6E986620-82BF-4F6E-9894-2F949F7EDC0FQ28475490-7C3DA0FA-84F1-4F0C-A068-7EDD241273C4Q28477353-E47EA587-D293-4A83-A7DC-1F64508995BDQ28513866-9723FE71-7C4D-4D8B-93A5-1B1BA40B96BEQ33219702-A0A1727F-67B2-451D-B624-C9FE98828001Q33477869-2D8CF751-972D-4A8E-AD6C-586B48DF66BDQ33695171-D51ED24D-D3BC-4458-9BF7-A52B5D0C81F4Q33709439-5DE3C891-2722-4D11-BE86-D4A62F698C50Q34116798-330FD520-D412-46FD-A1FC-94079E3AA53BQ34139335-493A12E0-1774-4A52-8D31-C78578AD555FQ34652394-03AA155B-5EFB-4539-82A4-92D4B1571B81Q34871781-332AE507-5B9F-4C16-BB5C-E33EEC2F8754Q34901968-5B2DCF7F-8195-4223-BC52-C9EF7BAF55DEQ36142370-8C4E4C47-3F3C-49E6-B1E0-5B8130C9180EQ36370019-1BCDDCA7-F88E-4368-8CE6-4DD005257F1FQ36623480-812EAA9B-1EA8-4EC3-A9D6-2A35863AC1A7Q36844333-C6865EA5-E6CD-49E3-81C5-8B2EFAFE31DAQ36945032-F8620D14-9514-407D-B7A1-83CB32004AD2Q37282607-8F51F0FB-05B9-4035-BE98-946F9AAE5A07Q37352637-3842D629-3B39-40A5-B59D-C02DC72C7CAEQ37366157-622E1439-902C-4B9D-A057-13FB314CB4D9Q37709935-B869DF27-029B-433E-838A-9E837AA1BA17Q38363629-8E58A55C-BFE3-4503-95C0-9D71D196E7DCQ38905381-D5228E7E-9BC4-49C0-8354-A55A8005A182Q38952778-C4B22C10-7B3C-4436-A614-E16B3B573D60Q39325885-E017ABEB-D3D7-4876-9100-91707AA1EE7FQ39451512-08415AA9-CE50-49FB-BC5C-D79ED46E51D5Q39458787-E9F2EB07-DE90-46CE-8E24-CFF3E37F69F7Q39527922-40653043-93FD-4458-B279-34AF24330CF9Q39799148-033CBAB5-950D-46AB-8BEE-06164411D888Q39828891-060DAD38-A1A4-4904-9CF4-0498C4884D99Q39879199-51B50584-80E2-41BB-9773-4A86B6D2231EQ40002386-D417FB69-7067-430B-BADC-85A75E716D7BQ40489044-A547CF72-912B-461F-9A5B-B08529E28690Q40599204-EE8F710E-3443-44DF-B6CD-C228B25C57BDQ40602553-1FE2E1F0-1A8A-4C85-90F7-290A77991581Q40810356-B56DB196-11F6-491B-8E23-746C4D9B8887
P2860
Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Microtubule inhibitors elicit ...... in human KB-3 carcinoma cells.
@en
Microtubule inhibitors elicit ...... in human KB-3 carcinoma cells.
@nl
type
label
Microtubule inhibitors elicit ...... in human KB-3 carcinoma cells.
@en
Microtubule inhibitors elicit ...... in human KB-3 carcinoma cells.
@nl
prefLabel
Microtubule inhibitors elicit ...... in human KB-3 carcinoma cells.
@en
Microtubule inhibitors elicit ...... in human KB-3 carcinoma cells.
@nl
P356
P1476
Microtubule inhibitors elicit ...... in human KB-3 carcinoma cells.
@en
P2093
P304
P356
10.1006/EXCR.1999.4731
P407
P577
2000-01-01T00:00:00Z